11682 Federal Register / Vol. 80, No. 42 / Wednesday, March 4, 2015 / Notices 

to learn about possible modifications 

before coming to the meeting. 

Agenda: On March 24, 2015, the 

Pediatric Advisory Committee (PAC) 

will meet to discuss pediatric-focused 

safety reviews, as mandated by the Best 

Pharmaceuticals for Children Act (Pub. 

L. 107–109) and the Pediatric Research 

Equity Act (Pub. L. 108–155). The PAC 

will meet to discuss the following 

products: CYMBALTA (duloxetine 

hydrochloride), QUILLIVANT XR 

(methylphenidate hydrochloride), 

LUNESTA (eszopiclone), RISPERDAL 

(risperidone), OXTELLAR XR 

(oxcarbazepine), REVATIO (sildenafil), 

ADVAIR HFA (fluticasone propionate/

salmeterol), DYMISTA (azelastine 

hydrochloride/fluticasone proprionate), 

QNASL (beclomethasone dipropionate), 

VENOFER (iron sucrose), INVIRASE 

(saquinavir), ALTABAX Ointment 

(retapamulin), FluMist 

QUADRIVALENT (influenza vaccine 

live, intranasal), FLUARIX 

QUADRIVALENT (influenza virus 

vaccine), Medtronic ACTIVA 

DYSTONIA THERAPY, and 

LIPOSORBER LA–15 System. In 

addition, there will be a short 

presentation of the ethical issues 

discussed by the Pediatric Ethics 

Subcommittee of the PAC on March 23, 

2015. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/

AdvisoryCommittees/Calendar/

default.htm. Scroll down to the 

appropriate advisory committee link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before March 16, 2015. 

Oral presentations from the public will 

be scheduled on March 24, 2015, 

between approximately 9 a.m. and 10 

a.m. Those individuals interested in 

making formal oral presentations should 

notify the contact person and submit a 

brief statement of the general nature of 

the evidence or arguments they wish to 

present, the names and addresses of 

proposed participants, and an 

indication of the approximate time 

requested to make their presentation on 

or before March 6, 2015. Time allotted 

for each presentation may be limited. If 

the number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, FDA may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by March 9, 2015. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

Agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Walter 

Ellenberg at least 7 days in advance of 

the meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/Advisory

Committees/AboutAdvisoryCommittees/

ucm111462.htm for procedures on 

public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: February 26, 2015. 

Jill Hartzler Warner, 

Associate Commissioner for Special Medical 

Programs. 

[FR Doc. 2015–04394 Filed 3–3–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, March 

05, 2015, 11:00 a.m. to March 05, 2015, 

05:00 p.m., National Institutes of Health, 

6701 Rockledge Drive, Bethesda, MD, 

20892 which was published in the 

Federal Register on February 24, 2015, 

80 FR 9738. 

The meeting will be held on March 

12, 2015. The meeting location and time 

remain the same. The meeting is closed 

to the public. 

Dated: February 25, 2015. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–04408 Filed 3–3–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Neurological 

Disorders and Stroke Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Neurological Disorders and Stroke Council. 

Date: May 28–29, 2015. 

Open: May 28, 2015, 8:00 a.m. to 3:00 p.m. 

Agenda: Report by the Director, NINDS; 

Report by the Associate Director for 

Extramural Research; Administrative and 

Program Developments; and an Overview of 

the NINDS Intramural Program. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 10, Bethesda, MD 20892. 

Closed: May 28, 2015, 3:00 p.m. to 4:45 

p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 10, Bethesda, MD 20892. 

Closed: May 28, 2015, 4:45 p.m. to 5:15 

p.m. 

Agenda: To review and evaluate the 

Division of Intramural Research Board of 

Scientific Counselors’ Reports. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 10, Bethesda, MD 20892. 

Closed: May 29, 2015, 8:00 a.m. to 11:00 

a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 10, Bethesda, MD 20892. 

Contact Person: Robert Finkelstein, Ph.D., 

Associate Director for Extramural Research, 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 42 / Wednesday, March 4, 2015 / Notices 11683 

National Institute of Neurological Disorders 

and Stroke, NIH, 6001 Executive Blvd., Suite 

3309, MSC 9531, Bethesda, MD 20892, (301) 

496–9248. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.ninds.nih.gov, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS). 

Dated: February 25, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–04407 Filed 3–3–15; 8:45 am] 

BILLING CODE 4140–01–P 

ADVISORY COUNCIL ON HISTORIC 

PRESERVATION 

Notice of Advisory Council on Historic 

Preservation Quarterly Business 

Meeting 

AGENCY: Advisory Council on Historic 

Preservation. 

ACTION: Notice of Advisory Council on 

Historic Preservation Quarterly Business 

Meeting. 

SUMMARY: Notice is hereby given that 

the Advisory Council on Historic 

Preservation (ACHP) will hold its next 

quarterly meeting on Thursday, March 

19, 2015. The meeting will be held in 

the Ortega Ballroom at the Officer’s Club 

on Moraga Avenue, The Presidio, San 

Francisco, California, starting at 8:00 

a.m. PST. 

DATES: The quarterly meeting will take 

place on Thursday, March 19, 2015, 

starting at 8:30 a.m. PST. 

ADDRESSES: The meeting will be held in 

the Ortega Ballroom at the Officer’s Club 

on Moraga Avenue, The Presidio, San 

Francisco, California. 

FOR FURTHER INFORMATION CONTACT: 

Cindy Bienvenue, 202–517–0202, 

cbienvenue@achp.gov. 

SUPPLEMENTARY INFORMATION: The 

Advisory Council on Historic 

Preservation (ACHP) is an independent 

federal agency that promotes the 

preservation, enhancement, and 

sustainable use of our nation’s diverse 

historic resources, and advises the 

President and the Congress on national 

historic preservation policy. The goal of 

the National Historic Preservation Act 

(NHPA), which established the ACHP in 

1966, is to have federal agencies act as 

responsible stewards of our nation’s 

resources when their actions affect 

historic properties. The ACHP is the 

only entity with the legal responsibility 

to encourage federal agencies to factor 

historic preservation into federal project 

requirements. For more information on 

the ACHP, please visit our Web site at 

www.achp.gov. 

The agenda for the upcoming 

quarterly meeting of the ACHP is the 

following: 

Call to Order—8:00 a.m. 

I. Chairman’s Welcome 

II. Historic Preservation Policy and 

Programs 

A. Building a More Inclusive 

Preservation Program 

1. Asian-American Pacific Islander 

Initiative 

2. American Latino Heritage Initiative 

B. Working with Native Americans 

1. Presentation by California Tribes 

2. ACHP Native American Affairs 

Committee Activities 

C. Preservation 50 and the ACHP 

Public Policy Initiative 

D. Historic Preservation Legislation in 

the 114th Congress 

1. ACHP Legislative Agenda 

2. Policy for Adoption of ACHP 

Legislative Positions 

E. Clement Price Scholar Program 

III. Section 106 Issues 

A. 2015 Section 3 Report to the 

President Implementation 

B. Alignment of Section 4f and 

Section 106 Reviews 

C. Federal Agency Support for SHPOs 

and THPOs 

IV. ACHP Management Issues 

A. Member CommunicationsRecommendations 

V. New Business 

VI. Adjourn 

The meetings of the ACHP are open 

to the public. If you need special 

accommodations due to a disability, 

please contact Cindy Bienvenue, 202– 

517–0202 or cbienvenue@achp.gov, at 

least seven (7) days prior to the meeting. 

Authority: 16 U.S.C. 470j. 

Dated: February 27, 2015. 

Javier E. Marques, 

Associate General Counsel. 

[FR Doc. 2015–04498 Filed 3–3–15; 8:45 am] 

BILLING CODE 4310–K6–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2015–0007] 

Office of Cybersecurity and 

Communications, National Protection 

and Programs Directorate Notice of 

Meeting Regarding Information 

Sharing and Analysis Organizations 

Authority: 6 U.S.C. 131–134; 6 CFR. 29; 

E.O. 13691. 

AGENCY: Office of Cybersecurity and 

Communications, National Protection 

and Programs Directorate. 

ACTION: Notice of Meeting. 

SUMMARY: This Notice announces a 

public meeting on March 18, 2015 to 

discuss Information Sharing and 

Analysis Organizations, cybersecurity 

information sharing, and the Executive 

Order 13691, ‘‘Promoting Private Sector 

Cybersecurity Information Sharing’’ of 

February 13, 2015. 

DATES: The meeting will be held on 

March 18, 2015, 9:00 a.m. to 11:30 a.m. 

The meeting may conclude before the 

allotted time if all matters for discussion 

have been addressed. Submit comments 

on or before April 19, 2015 at 11:59 p.m. 

In the event DHS does not have 

appropriations by 11:59 p.m. on March 

16, 2015, this notice and the meeting is 

cancelled. 

ADDRESSES: The meeting location is in 

Arlington—Navy League of the United 

States, 2300 Wilson Boulevard, 

Arlington, VA 22201. See 

Supplementary Information section for 

the address to submit written or 

electronic comments. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions concerning the 

meeting, please contact ISAO@

hq.dhs.gov or Michael A. Echols, 

Director, JPMO, Department of 

Homeland Security, michael.echols@

dhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background and Purpose 

On February 13, 2015, President 

Obama signed Executive Order 13691 

intended to enable and facilitate 

‘‘private companies, nonprofit 

organizations, and executive 

departments and agencies . . .to share 

information related to cybersecurity 

risks and incidents and collaborate to 

mstockstill on DSK4VPTVN1PROD with NOTICES